ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 185049 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 185049; 2) Community: the network communities that were significantly associated with the response to NSC 185049; 3) Molecule: the relationships between components within communities and NSC 185049; 4) MDR: the compounds that were significantly associated with the NSC 185049.

NSC Compound Enrichment Correlation
NSC 683556 Camptothecin Derivative 0.00803384002766641 0.63378869
NSC 685828 7H-Purine, 6-chloro-7-[2-deoxy-3-O-(4-methylphenyl)- 4-(4-methylphenoxy)-.beta.-D-erythrofuranosyl]- 0.00803384002766641 0.46572922
NSC 700363 Liposomal Annamycin 0.00803384002766641 0.37453108
NSC 726365 Null 0.00803384002766641 0.20677065
NSC 727729 1, 1'[Pentane-1,5-diyl)dioxy]bis(11as)-2-fluoro-7-methoxy-1,2,3 ,11a-tetrahydro-5H-pyrrolo[2,1-c][1,4]benzodiazepin-5-one 0.00803384002766641 0.4853501
NSC 88916 10,13-dimethyl-17-(2-methyl-1,3-thiazol-4-yl)-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-one 0.00803384002766641 0.20388803
NSC 529180 Arafluorocytosine 0.0107933723273943 0.30743121
NSC 619674 Null 0.0107933723273943 0.40322552
NSC 650263 Null 0.0107933723273943 0.17662722
NSC 691251 Null 0.0107933723273943 0.26712651
Total:47  Current:10    [First] [Prev] [Next] [Last]